EGFR and gastric cancer: The combination of anti-EGFR therapy with chemotherapy provides a basis for the treatment of resistant GC patients.Several phase II clinical trials demonstrated the benefit of combination chemotherapy and anti-EGFR therapy in GC patients [31–33], so we tried drug susceptibility testing with AZD9291, but the results were not satisfactory.